Stocks With The Highest
Upside Forecast

Based on 25,000+ 1-year price targets provided by 5,000+ Wall Street analysts over the past 3-months

#	Name	Upside %	Analysts bullish %
76	76 Viridian Therapeutics VRDN $1.39B	111% upside 5 price targets	0
77	77 Sana Biotechnology SANA $999M	111% upside 3 price targets	0
78	78 GH Research GHRS $1.06B	110% upside 3 price targets	0
79	79 Castle Biosciences CSTL $513M	110% upside 3 price targets	0
80	80 Eton Pharmaceutcials ETON $379M	110% upside 3 price targets	0
81	81 IDEAYA Biosciences IDYA $1.95B	109% upside 3 price targets	0
82	82 AnaptysBio ANAB $795M	107% upside 3 price targets	0
83	83 Celcuity CELC $528M	106% upside 3 price targets	0
84	84 Ultragenyx Pharmaceutical RARE $2.62B	104% upside 5 price targets	0
85	85 Savara SVRA $403M	104% upside 4 price targets	0
86	86 Denali Therapeutics DNLI $2.11B	103% upside 4 price targets	0
87	87 Phathom Pharmaceuticals PHAT $565M	102% upside 5 price targets	0
88	88 Avidity Biosciences RNA $4.02B	101% upside 9 price targets	0
89	89 Jamf JAMF $1.09B	100% upside 6 price targets	0
90	90 Sutro Biopharma STRO $68M	99% upside 3 price targets	0
91	91 Arcus Biosciences RCUS $1,000M	99% upside 4 price targets	0
92	92 New Fortress Energy NFE $1.22B	99% upside 3 price targets	0
93	93 BioCryst Pharmaceuticals BCRX $1.81B	98% upside 8 price targets	0
94	94 Celldex Therapeutics CLDX $1.53B	97% upside 5 price targets	0
95	95 Waldencast WALD $294M	95% upside 3 price targets	0
96	96 Vertical Aerospace EVTL $625M	93% upside 4 price targets	0
97	97 Liquidia Corp LQDA $1.23B	92% upside 7 price targets	0
98	98 Holley HLLY $270M	89% upside 3 price targets	0
99	99 Enovis ENOV $1.73B	88% upside 4 price targets	0
100	100 Tandem Diabetes Care TNDM $1.02B	88% upside 7 price targets	0

1 23456

65